Nikola Slijepcevic

Dr. Nikola Slijepcevic

Clinic for endocrine surgery, University Clinical Center, Serbia, Belgrade, Belgrade, Beograd, Serbia
+1
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2017 in BMC Cancer
Verified
Journal Article
Open access
PDF file
BOBranisav Oluic
Branisav Oluic
IPIvan Paunovic
Ivan Paunovic
ZLZlatibor Loncar
Zlatibor Loncar
VDVladimir Djukic
Vladimir Djukic
ADAleksandar Diklic
Aleksandar Diklic
Vladan ZivaljevicVladan Zivaljevic
Vladan Zivaljevic
Hurthle cell carcinoma makes up 3 to 5% of all thyroid cancers and is considered to be a true rarity. The aim of our study was to analyze clinical characteristics and survival rates of patients with Hurthle cell carcinoma. Clinical data regarding basic demographic characteristics, tumor grade, type of surgical treatment and vital status were collected. Methods of descriptive statistics and Kaplan-Meier survival curves were used for statistical analysis. Cox proportional hazards regression was used to identify independent predictors. During the period from 1995 to 2014, 239 patients with Hurthle cell carcinoma were treated at our Institution. The average age of the patients was 54.3, with female to male ratio of 3.6:1 and average tumor size was 41.8 mm. The overall recurrence rate was 12.1%, with average time for relapse of 90.74 months and average time without any signs of the disease of 222.4 months. Overall 5-year, 10-year and 20-year survival rates were 89.4%, 77.2%, 61.9% respectively. The 5-year, 10-year and 20-year cancer specific survival rates were 94.6%, 92.5%, 87.4%, respectively. When disease free interval was observed, 5-year, 10-year and 20-year rates were 91.1%, 86.2%, 68.5%, respectively. The affection of both thyroid lobes and the need for reoperation due to local relapse were unfavorable independent prognostic factors, while total thyroidectomy as primary procedure was favorable predictive factor for cancer specific survival. Hurthle cell carcinoma is a rare tumor with an encouraging prognosis and after adequate surgical treatment recurrences are rare.

30 April 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Nikola SlijepcevicNikola Slijepcevic
Nikola Slijepcevic
Vladan ZivaljevicVladan Zivaljevic
Vladan Zivaljevic
JMJelena Marinkovic
Jelena Marinkovic
SGSandra Sipetic Grujicic
Sandra Sipetic Grujicic
ADAleksandar Diklic
Aleksandar Diklic
IPIvan Paunovic
Ivan Paunovic
The aim of our study was to investigate the incidence of papillary thyroid microcarcinoma (PTMC) in patients operated for benign thyroid diseases (BTD) and its relation to age, sex, extent of surgery and type of BTD. Retrospective study of 2466 patients who underwent thyroid surgery for BTD from 2008 to 2013. To determine independent predictors for PTMC we used three separate multivariate logistic regression models (MLR). There were 2128 (86.3%) females and 338 (13.7%) males. PTMC was diagnosed in 345 (16.2%) females and 58 (17.2%) males. Age ranged from 14 to 85 years (mean 54 years). Sex and age were not related to the incidence of PTMC. The overall incidence of PTMC was 16.3%. The highest incidence was in Hashimoto thyroiditis (22.7%, χ2 = 10.80, p < 0.001); and in patients with total/near-total thyroidectomy (17.7%, χ2 = 7.05, p < 0.008). The lowest incidence (6.6%, χ2 = 9.96, p < 0.001) was in a solitary hyperfunctional thyroid nodule (SHTN). According to MLR, Hashimoto thyroiditis (OR 1.54, 95% CI 1.15-2.05, p < 0.003) and SHTN (OR 0.43, 95% CI 0.21-0.87, p < 0.019) are independent predictors. Since the extent of surgery was an independent predictor (OR 1.45, 95% CI 1.10-1.92, p = 0.009) for all BTD, and sex and age were not; when the MLR model was adjusted for them, Graves disease (OR 0.72, 95% CI 0.53-0.99, p < 0.041) also proved to be an independent predictor. Sex and age are not statistically related to the incidence of PTMC in BTD. The incidence of PTMC is higher in Hashimoto thyroiditis and patients with total/near-total thyroidectomy; and lower in patients with a SHTN and Graves disease.

9 April 2015 in BMC Surgery
Verified
Journal Article
Open access
PDF file
TBToplica Bojic
Toplica Bojic
IPIvan Paunovic
Ivan Paunovic
ADAleksandar Diklic
Aleksandar Diklic
Vladan ZivaljevicVladan Zivaljevic
Vladan Zivaljevic
GZGoran Zoric
Goran Zoric
AKAleksandar Karanikolic
Aleksandar Karanikolic
Graves’ disease represents an autoimmune disease of the thyroid gland where surgery has an important role in its treatment. The aim of our paper was to analyze the results of surgical treatment, the frequency of microcarcinoma and carcinoma, as well as to compare surgical complications in relation to the various types of operations performed for Graves’ disease. We analysed 1432 patients (221 male and 1211 female) who underwent surgery for Graves’ disease at the Centre for Endocrine Surgery in Belgrade during 15 years (1996–2010). Average age was 34.8 years. Frequency of surgical complications within the groups was analyzed with nonparametric Fisher’s test. Total thyroidectomy (TT) was performed in 974 (68%) patients, and Dunhill operation (D) in 221 (15.4). Carcinoma of thyroid gland was found in 146 patients (10.2%), of which 129 (9%) were a microcarcinoma. Complication rates were higher in the TT group, where there were 31 (3.2%) patients with permanent hypoparathyroidism, 9 (0.9%) patients with unilateral recurrent nerve paralysis and 10 (1.0%) patients with postoperative bleeding. Combined complications, such as permanent hypoparathyroidism with bleeding were more common in the D group where there were 2 patients (0,9%), while unilateral recurrent nerve paralysis with bleeding was more common in the TT group where there were 3 cases (0,3%). Frequency of complications were not significantly statistically different in relation to the type of surgical procedure. Total thyroidectomy represents a safe and efficient method for treating patients with Graves’ disease, and it is not followed by a greater frequency of complications in relation to less extensive procedures.

27 May 2015 in BMC Urology
Verified
Journal Article
Open access
PDF file
ZLZlatibor Loncar
Zlatibor Loncar
VDVladimir Djukic
Vladimir Djukic
Vladan ZivaljevicVladan Zivaljevic
Vladan Zivaljevic
TPTatjana Pekmezovic
Tatjana Pekmezovic
ADAleksandar Diklic
Aleksandar Diklic
IPIvan Paunovic
Ivan Paunovic
Adrenocortical carcinoma (ACC) is aggressive, but rare tumours that have not been sufficiently studied. The aim of our study was to present the demographic and clinical characteristics of patients with ACC, to determine the overall survival rates, analyse the effect of prognostic factors on survival, as well as to identify favorable and unfavourable predictors of survival. The study included 72 patients (42 women and 30 men) with ACC. We analysed the prognostic value of the demographic and clinical characteristics of the patients, tumour characteristics, therapy administered and survival rates. Kaplan-Meier survival curves and the log-rank test were used to estimate the overall and specific survival probabilities and the Cox regression model was used to identify independent prognostic factors for survival. The patients had mean age of 50 years. The 1-, 5-, and 10-year probabilities of survival in patients with ACC were 52.5 %, 41.1 %, and 16.4 %, respectively. The median survival time was 36 months. The results of multivariate Cox regression analysis showed that the presence of lymphatic metastases (HR = 7.37, 95 % CI = 2.31-23.48, p = 0.001) and therapy with mitotane (HR = 0.11, 95 % CI = 0.04-0.27, p = 0.001) were independent prognostic factors for survival. The presence of lymphatic metastasis is an unfavourable prognostic factor, while postoperative therapy with mitotane is a favorable prognostic factor for survival in patients with ACC.

1 January 2009 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
SJSnezana Jesic
Snezana Jesic
SSSvetlana Stosic
Svetlana Stosic
BMBranislava Milenkovic
Branislava Milenkovic
VNVladimir Stanimir Nesic
Vladimir Stanimir Nesic
ZDZoran Dudvarski
Zoran Dudvarski
Nikola SlijepcevicNikola Slijepcevic
Nikola Slijepcevic
Introduction. Tuberculous otitis is a diagnostic problem due to the difficulty to obtain microbiological, histomorphological and cytological confirmation of the disease. Objective. Our objective was to compare clinical and radiological characteristic and development of otogenic complications in patients with tuberculous otitis and otitis with cholesteatoma as the most destructive form of chronic nonspecific otitis in the purpose of establishing the diagnostic criteria for tuberculous otitis. Methods. Medical records of 12 patients with tuberculous otitis and 163 patients with cholesteatoma treated at the Institute of Otorhinolaryngology and Maxillofacial Surgery in Belgrade during the eight-year period were analyzed. All of the patients underwent otomicroscopic, audiological and radiological examination of the thorax and temporal bone, microbiological examination of the secretion and histomorphological examination of the tissue taken during middle ear surgery. Statistical analysis was done using ?2 test with Yates correction. Results. Otogenic complication as facial palsy and sensorineural hearing loss were more frequent in tuberculous otitis patients, than in cholesteatoma. Also, fistulas of the labyrinth and facial canal bone destruction were also more frequent in tuberculous otitis than in cholesteatoma. A larger extent of temporal bone destruction was noticed on CT scans of the temporal bone in half of the patents with tuberculous otitis. Coexistence with miliary pulmonary tuberculosis was detected in one third of the patients. There were no microbiological or histomorphological confirmations of the disease, except in one case with positive Ziehl-Neelsen staining. Conclusion. Tuberculous otitis media should be considered in patients with serious otogenic complications and with shorter duration of ear discharge, and in association with diagnosed miliary pulmonary tuberculosis and extensive temporal bone destruction. Polymerase chain reaction still is not reliable for diagnosis.

21 February 2011 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
SJSnezana D. Jesic
Snezana D. Jesic
MDMilovan V. Dimitrijevic
Milovan V. Dimitrijevic
VNVladimir Stanimir Nesic
Vladimir Stanimir Nesic
AJAna Dragan Jotic
Ana Dragan Jotic
Nikola SlijepcevicNikola Slijepcevic
Nikola Slijepcevic
Modern tympanoplasty is successful in radical eradication of pathologic processes owing to microscopic and endoscopic control, preoperative computed tomography, and nuclear magnetic resonance imaging. However, inadequate aeration is unresolved in tympanoplasty. Negative tympanic cavity pressure can lead to ossicular osteolysis, extrusion of the prosthesis, or recurrent perforation and retraction of the graft. Attention has been directed to the choice of grafting material, which should be mechanically stable and have necessary acoustic performance for good sound transmission. Autologous materials such as temporalis fascia, cartilage, and perichondrium provide these characteristics, and each has specific advantages and disadvantages. Studies1-3 have shown that cartilage and temporalis fascia are associated with minimal tissue reaction and absorption; temporalis fascia shows particularly poorer dimensional stability and significant shrinkage after rehydrating. In contrast, some investigations have demonstrated loss of acoustic energy using thick-shield cartilage grafting, while others have shown the opposite.4 The choice of temporalis fascia or cartilage should not be one of surgeon preference but should be derived based on knowledge of different prognostic aspects such as demographic factors, disease-associated issues, and technical reasons (perioperative bleeding, the use of a graft that is too small, etc).5,6